A
A

AstraZeneca


خبر

AstraZeneca says early trial data indicates third dose helps against Omicron

By Pushkala Aripaka and Ludwig Burger Jan 13 (Reuters) - AstraZeneca AZN.L said on Thursday that preliminary data from a trial showed that its COVID-19 shot, Vaxzevria, generated an increase in antibodies against the Omicron and other variants when given as a third booster dose. The increased response, also against the Delta variant, was seen in a
A
P

UK Stocks-Factors to watch on Jan 13

Jan 13 (Reuters) - Britain's FTSE 100 .FTSE index is seen opening lower, with futures FFIc1 down 0.1% on Thursday. * M&S: British retailer Marks & Spencer MKS.L nudged up its profit outlook after it reported a strong Christmas performance, particularly in food, where it outperformed the market. * ASTRAZENECA: AstraZeneca AZN.L said new data from tr
A
M
M
P
T
W
U

AstraZeneca says higher antibody response against Omicron with booster dose

Jan 13 (Reuters) - AstraZeneca AZN.L said on Thursday new data from trials showed there was a higher antibody response against the Omicron coronavirus variant and others, including Beta, Delta, Alpha and Gamma, when its vaccine was given as a third booster dose. Reporting by Pushkala Aripaka in Bengaluru; Editing by Subhranshu Sahu
A

UK Stocks-Factors to watch on Jan 13

Jan 13 (Reuters) - Britain's FTSE 100 .FTSE index is seen opening lower, with futures FFIc1 down 0.1% on Thursday. * ASTRAZENECA: AstraZeneca AZN.L said on Wednesday the U.S. government has agreed to purchase an additional 500,000 doses of its antibody cocktail, Evusheld, used to prevent COVID-19. * FINANCE: Britain's financial services grew for th
A
M
M
P
T
W
U

Yields higher after progress on Omicron, rising stocks

By Ross Kerber Dec 23 (Reuters) - Traders steepened the U.S. Treasury yield curve on Thursday as stock markets rose on optimism about the public health impact of the Omicron coronavirus variant. The benchmark 10-year yield US10YT=RR was up 3.5 basis points at 1.4926% in afternoon trading, with Treasury markets set to close early at 2 p.m. ET (1900
A

Pound lifted to one-month high by gilt yield rise, Omicron reassurance

By Sujata Rao LONDON, Dec 23 (Reuters) - Sterling vaulted above $1.34 for the first time in a month on Thursday and also scaled a one-month high against the euro, surfing a general uptick in risk sentiment and a steep rise in Britain's short-dated government bond yields. UK businesses posted the weakest quarterly growth since the three months to Ap
A

Soothing Omicron news helps lift pound to one-month high

LONDON, Dec 23 (Reuters) - Sterling rose to a one-month high against the dollar on Thursday and firmed a quarter percent to the euro, benefiting from a general improvement in risk sentiment triggered by soothing reports on the Omicron COVID-19 variant. A three-dose course of AstraZeneca's AZN.L COVID-19 vaccine is effective against Omicron, the com
A

Vaccines, pills and data offer some Christmas cheer in face of Omicron advance

* AstraZeneca, Novavax say their shots protect against Omicron * UK data suggests fewer hospitalisations compared with Delta * Do not extrapolate from South African data -African CDC boss * WHO also urges caution about drawing firm conclusions By James Macharia Chege and Josephine Mason JOHANNESBURG/LONDON, Dec 23 (Reuters) - Omicron advanced acros
A
P

The fairy tale of Wall Street

A look at the day ahead from Sujata Rao Omicron spreads faster than Delta but is less likely to land you in hospital. The UK now has more than 100,000 cases of Omicron. China's Xian city has locked down 13 million residents. But a third Astra Zeneca shot offers protection. And so on. But... whatever. Markets seem to be reposing their trust in compa
A
U

AstraZeneca vaccine booster works against Omicron, Oxford lab study finds

* Antibody levels with booster similar to two doses against Delta * Protection also higher than those previously infected * Oxford researchers independent from vaccine partners By Pushkala Aripaka Dec 23 (Reuters) - A three-dose course of AstraZeneca's AZN.L COVID-19 vaccine is effective against the rapidly-spreading Omicron coronavirus variant, th
A

Oil rallies on reduced fears of Omicron-induced demand slump

* Two antiviral pills for COVID-19 approved in U.S. * Exxon to adjust production at fire-hit Baytown refinery * U.S. rig count up to highs since early 2020 (Updates with settlement prices, weekly change) By David Gaffen NEW YORK, Dec 23 (Reuters) - Oil prices bounced in a light-volume session on Thursday on signs that the worst effects of the Omicr
A
P
O
B

UK Stocks-Factors to watch on Dec. 22

Dec 22 (Reuters) - Britain's FTSE 100 .FTSE index is seen opening higher on Wednesday, with futures FFIc1 up 0.28%. * METRO BANK: The Bank of England's Prudential Regulation Authority has fined Metro Bank METRO.L 5.38 million pounds ($7.13 million) for failures in its regulatory reporting governance and controls, it said. * TAYLOR WIMPEY: UK's thir
A
N
P
B
R
T
U

UK Stocks-Factors to watch on Dec. 22

Dec 22 (Reuters) - Britain's FTSE 100 .FTSE index is seen opening higher on Wednesday, with futures FFIc1 up 0.21%. * NATWEST: A unit of NatWest Group NWG.L agreed to pay about $35 million and pleaded guilty to wire and securities fraud in relation to a long-running scheme by some of its traders to manipulate U.S. Treasury debt markets. * BHP GROUP
A
B
R
U

Financial Times - Dec. 22

Dec 21 (Reuters) - The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy. Headlines Israel plans to administer fourth dose of coronavirus vaccine Link Oxford and AstraZeneca launch work on Omicron-targeted version of vaccine Link Taiwan to restrict tech companies' sale
A

UK's Johnson says: we're looking all kinds of things to tackle Omicron

(Recasts headline and lead) LONDON, Dec 20 (Reuters) - British Prime Minister Boris Johnson said on Monday that he was looking at all kinds of things to keep the Omicron variant under control as the situation was extremely difficult, cautioning that further restrictions might be needed. "I have to say to the British public, and I say to everybody,
A
P

UK's Johnson warns: we can't exclude further action on COVID

LONDON, Dec 20 (Reuters) - British Prime Minister Boris Johnson said on Monday that he would take further action to tackle the spread of the Omicron variant of the coronavirus if necessary. Johnson said the situation was "extremely difficult" and that hospitalisations were rising steeply in London. "We will have to reserve the possibility of taking
A
P

EU regulator backs Novavax shot as region's fifth 19 vaccine

Dec 20 (Reuters) - The European Union's drug regulator on Monday approved use of the COVID-19 vaccine from U.S.-based Novavax NVAX.O in people 18 years and older, paving the way for a fifth coronavirus shot in the region as the Omicron coronavirus variant spreads. Data from two large studies showed the vaccine has an efficacy of around 90%, the Eur
A
P

EU regulator backs Novavax as region's fifth 19 vaccine

Dec 20 (Reuters) - The European Union's drug regulator said on Monday it has approved the COVID-19 vaccine from U.S.-based Novavax NVAX.O for use in adults, paving the way for a fifth coronavirus shot in the EU as the Omicron coronavirus variant spreads. FACTBOX-What COVID-19 vaccine and drug makers have to say about Omicron Novavax says it could s
A
P

UK Stocks-Factors to watch on Dec 20

Dec 20 (Reuters) - Britain's FTSE 100 .FTSE index is seen opening lower on Monday, with futures FFIc1 down 1.88%. * STANDARD CHARTERED: The Bank of England said it will fine Standard Chartered STAN.L 46.55 million pounds ($61.51 million) for misreporting its liquidity position to the regulator and for failings in its controls. * BARCLAYS: UK-based
A
A
B
G
S
T
A
R
U

UK Stocks-Factors to watch on Dec. 20

Dec 20 (Reuters) - Britain's FTSE 100 .FTSE index is seen opening lower on Monday, with futures FFIc1 down 1.43%. * RIO TINTO: Rio Tinto RIO.L RIO.AX tapped Canada's outgoing ambassador to China as its chairman, hoping the veteran consultant's links to its biggest market will help the global miner as it looks to move on from the scandal over its de
A
A
G
T
R
U



شرائط

مشہور اثاثے

دستبرداری: XM Group کے ادارے ہماری آن لائن تجارت کی سہولت تک صرف عملدرآمد کی خدمت اور رسائی مہیا کرتے ہیں، کسی شخص کو ویب سائٹ پر یا اس کے ذریعے دستیاب کانٹینٹ کو دیکھنے اور/یا استعمال کرنے کی اجازت دیتا ہے، اس پر تبدیل یا توسیع کا ارادہ نہیں ہے ، اور نہ ہی یہ تبدیل ہوتا ہے یا اس پر وسعت کریں۔ اس طرح کی رسائی اور استعمال ہمیشہ مشروط ہوتا ہے: (i) شرائط و ضوابط؛ (ii) خطرہ انتباہات؛ اور (iii) مکمل دستبرداری۔ لہذا اس طرح کے مواد کو عام معلومات سے زیادہ کے طور پر فراہم کیا جاتا ہے۔ خاص طور پر، براہ کرم آگاہ رہیں کہ ہماری آن لائن تجارت کی سہولت کے مندرجات نہ تو کوئی درخواست ہے، اور نہ ہی فنانشل مارکیٹ میں کوئی لین دین داخل کرنے کی پیش کش ہے۔ کسی بھی فنانشل مارکیٹ میں تجارت میں آپ کے سرمائے کے لئے ایک خاص سطح کا خطرہ ہوتا ہے۔

ہماری آن لائن تجارتی سہولت پر شائع ہونے والے تمام مٹیریل کا مقصد صرف تعلیمی/معلوماتی مقاصد کے لئے ہے، اور اس میں شامل نہیں ہے — اور نہ ہی اسے فنانشل، سرمایہ کاری ٹیکس یا تجارتی مشورے اور سفارشات؛ یا ہماری تجارتی قیمتوں کا ریکارڈ؛ یا کسی بھی فنانشل انسٹرومنٹ میں لین دین کی پیشکش؛ یا اسکے لئے مانگ؛ یا غیر متنازعہ مالی تشہیرات پر مشتمل سمجھا جانا چاہئے۔

کوئی تھرڈ پارٹی کانٹینٹ، نیز XM کے ذریعہ تیار کردہ کانٹینٹ، جیسے: راۓ، خبریں، تحقیق، تجزیہ، قیمتیں اور دیگر معلومات یا اس ویب سائٹ پر مشتمل تھرڈ پارٹی کے سائٹس کے لنکس کو "جیسے ہے" کی بنیاد پر فراہم کیا جاتا ہے، عام مارکیٹ کی تفسیر کے طور پر، اور سرمایہ کاری کے مشورے کو تشکیل نہ دیں۔ اس حد تک کہ کسی بھی کانٹینٹ کو سرمایہ کاری کی تحقیقات کے طور پر سمجھا جاتا ہے، آپ کو نوٹ کرنا اور قبول کرنا ہوگا کہ یہ کانٹینٹ سرمایہ کاری کی تحقیق کی آزادی کو فروغ دینے کے لئے ڈیزائن کردہ قانونی تقاضوں کے مطابق نہیں ہے اور تیار نہیں کیا گیا ہے، اسی طرح، اس پر غور کیا جائے گا بطور متعلقہ قوانین اور ضوابط کے تحت مارکیٹنگ مواصلات۔ براہ کرم یقینی بنائیں کہ آپ غیر آزاد سرمایہ کاری سے متعلق ہماری اطلاع کو پڑھ اور سمجھ چکے ہیں۔ مذکورہ بالا معلومات کے بارے میں تحقیق اور رسک وارننگ ، جس تک رسائی یہاں حاصل کی جا سکتی ہے۔

ہم کوکیز کا استعمال آپکو ہماری ویب سائٹ پر بہتریں تجربہ دینے کیلیے کرتے ہیں۔ مزید پڑھیے یا اپنی کوکی سیٹنگ تبدیل کیجیے۔

خطرے کی انتباہ: آپکا سرمایہ خطرے پر ہے۔ ہو سکتا ہے کہ لیورج پروڈکٹ سب کیلیے موزوں نہ ہوں۔ براہ کرم ہمارے مکمل رسک ڈسکلوثر کو پڑھیے۔